Managing progressive myopia in children requires solutions backed by rigorous clinical data. A recent two-year multicenter randomized clinical trial published in the American Journal of Ophthalmology (Chen et al., 2025) provides compelling evidence supporting the efficacy of spectacle lenses incorporating Cylindrical Annular Refractive Elements (CARE).
Key Clinical Takeaways from the Two-Year Trial
- Significant Slowing of Progression: Over the 24-month period, both evaluated CARE lens designs yielded significantly better results in slowing spherical equivalent (SE) progression and axial length (AL) elongation compared to standard single vision (SV) spectacle lenses.
- Measurable Reductions: CARE lenses demonstrated an absolute difference in SE progression, and a meaningful reduction in axial elongation compared to single vision controls.
- Higher Probability of Protection: Eyes wearing CARE lenses successfully survived fast progression over two years, compared to the single vision group.
For eye care professionals dedicated to staying at the clinical edge of myopia management, these findings reinforce the value of incorporating advanced optical designs into daily practice to deliver predictable, evidence-led outcomes for growing eyes.
